Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: David Howe who wrote (3362)	6/25/1999 7:13:00 PM
From: Bob Swift	Read Replies (1) \| Respond to of 10280

By counting on my fingers, the salesmen need to generate $1 million new Xopenex sale each month to meet the target of $30-33 millions for 1999 projected by Lind and accepted as comfortable with it by SEPR. Thus, we should see a minimum of $3 millions sales this quarter (months of May and June together)just to meet the projection.(Next quarter should be 12 millions =3+4+5 millions). Anything short of 3 millions this quarter,say less than a million, could be fatal and I will run like hell, at least short term-wise.